ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS (RHHBY) - Price, trends, fundamentals and chart - Passport to Wall Street

ROCHE HOLDINGS AG SPN ADR EACH REP 0.125 GENUS (OTCi: RHHBY)

Overview

current price

$36.86

$36.86

change

-0.24 | -0.65%

-0.24 | -0.65%

Yesterday's Close

37.10

open

36.64

volume

2.49 M

30d. avg volume.

4.48 M

1 day

36.02 - 36.97

52 weeks

29.20 - 44.31

p/e

0.00

beta

0.4586

market cap

208.52 B

dividend yield

0.00%

Industry

-

News and Commentary

Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline U.S. President Donald Trump, on Tuesday, disclosed plans for a "major tariff" on foreign pharmaceuticals."We're going to be announcing very shortly a ma...

Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Stra... Labcorp Holdings Inc (LH...

Pfizer And Roche Advance On Their Weight Loss Drug Journeys After previously discounting a twice-daily version of its weight loss drug due to patients having difficulties tolerating it, Pfizer Inc

Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Sta... Wednesday, Roche Holdings AG (

AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...

Biogen’s Alzheimer Drug Shows Promise in Key Study For the first time, a drug has been shown to

Merck Seeks Approval for First Pill To Treat COVID-19

Roche Rheumatoid Arthritis Drug Found to Reduce Death in Severely-Ill COVID Patients, Says Oxford St... Oxfordy University's ongoing Randomized Evaluation of COVID-19 Therapy (RECOVERY) clinical trials have demonstrated that the anti-inflammatory drug tocilizumab developed by the p...

C.D.C. to Test Sewage Water to Find Early Coronavirus Outbreaks The widespread, nationwide coronavirus outbreak in the United States is pushing the country's testing infrastructure to its limits in recent months, issuing a dark omen for the c...

Coronavirus Update: South Korea Enters Second Wave, Gilead to Test Inhaled Version of Remdesivir The coronavirus pandemic has dug its roots deep all throughout the world, with nations continuing to struggle against their first or even second waves of outbreak in an ongoing a...

StockTwits

StockTwits